title: [Serum beta 2 microglobulin (beta 2M) following renal transplantation].
abstract: Although there was an important improvement in graft and patient survival the last 10 years, graft rejection continues to be a major barrier to the success of renal transplantation. Identification of a laboratory test that could help to diagnose graft rejection would facilitate the management of renal transplanted patients. PURPOSE--To evaluate the utility of monitoring serum beta 2M in recently transplanted patients. METHODS--We daily determined serum beta 2M levels in 20 receptors of renal grafts (10 from living related and 10 from cadaveric donors) and compared them to their clinical and laboratory evolution. RESULTS--Eight patients who presented immediate good renal function following grafting and did not have rejection had a mean serum beta 2M of 3.7 mg/L on the 4th day post transplant. The sensitivity of the test for the diagnosis of acute rejection was 87.5%, but the specificity was only 46%. Patients who presented acute tubular necrosis (ATN) without rejection had a progressive decrease in their serum levels of beta 2M, while their serum creatinine changed as they were dialyzed. In contrast, patients with ATN and concomitance of acute rejection or CSA nephrotoxicity presented elevated beta 2M and creatinine serum levels. CONCLUSION--Daily monitoring of serum beta 2M does not improve the ability to diagnose acute rejection in patients with good renal function. However, serum beta 2M levels seemed to be useful in diagnosing acute rejection or CSA nephrotoxicity in patients with ATN.
authors.affiliation: Departamento de Medicina, da Escola Paulista de Medicina, São Paulo.
authors.forename: A
authors.initials: A
authors.lastname: Pacheco-Silva
authors.forename: S K
authors.initials: SK
authors.lastname: Nishida
authors.forename: M S
authors.initials: MS
authors.lastname: Silva
authors.forename: O L
authors.initials: OL
authors.lastname: Ramos
authors.forename: H
authors.initials: H
authors.lastname: Azjen
authors.forename: A B
authors.initials: AB
authors.lastname: Pereira
mesh_terms: D000293:Adolescent; D000328:Adult; D015415:Biomarkers / Q000097:blood; D003404:Creatinine / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000175:diagnosis; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation; D007683:Kidney Tubular Necrosis, Acute / Q000175:diagnosis; D008297:Male; D008875:Middle Aged; D015166:Monitoring, Immunologic; D011184:Postoperative Period; D001613:beta 2-Microglobulin / Q000032:analysis*
chemical_list: D015415:Biomarkers; D007166:Immunosuppressive Agents; D001613:beta 2-Microglobulin; D003404:Creatinine
vernacular_title: beta 2 microglobulina (beta 2M) sérica na monitorização do transplante renal.